XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (32,522) $ (5,852)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Loss on extinguishment of debt 0 16,096
Stock-based compensation expense 3,339 1,613
Non-cash interest expense 0 8
Amortization of debt issuance costs and debt discount (0) 150
Depreciation and amortization expense 644 193
Fair value adjustment related to derivative and warrant liability (295) 92
Fair value adjustment related to investments 634 0
Loss on sublease and disposal of property and equipment 9 76
Consulting fees paid in common stock 165 227
Acquired in-process research and development 17,663 0
Change in assets and liabilities:    
Accounts and other receivables (4,646) 960
Prepaid expenses and other assets (1,196) (1,366)
Inventories 280 0
Operating lease right-of-use assets 82 88
Accounts payable and accrued expenses 1,262 (1,891)
Discount and rebate liabilities 858 0
Operating lease liabilities (160) (241)
Other liabilities (372) 1,134
Net cash (used in) provided by operating activities (14,255) 11,287
Cash flows from investing activities:    
Acquisitions, net (14,090) 0
Purchases of property and equipment (59) (85)
Purchases of investments (23,832) 0
Maturities of investments 1,325 0
Net cash used in investing activities (36,656) (85)
Cash flows from financing activities:    
Proceeds from issuance of debt 12,800 0
Proceeds from Public Offering, net of discounts and commissions 0 49,285
Proceeds from Inducement Transaction, net of discounts and commissions 0 36,751
Proceeds from insurance financing arrangements 1,273 0
Proceeds from Employee Stock Purchase Plan 216 0
Payments of principal on insurance financing arrangements (876) 0
Payment to repurchase shares as part of the Share Repurchase Program (4,723) 0
Payment of offering costs (68) (1,299)
Repayment of principal on finance lease liabilities (13) (156)
Payment of debt issuance costs 0 (2,881)
Repayment of principal on convertible notes 0 (37,924)
Net proceeds from exercise of common stock warrants 0 30,819
Net cash provided by financing activities 8,609 115,979
Effect of exchange rate changes on cash and cash equivalents 15 0
Net (decrease) increase in cash and cash equivalents (42,287) 127,181
Cash and cash equivalents, beginning of period 112,346 4,322
Cash and cash equivalents, end of period 70,059 131,503
Supplemental cash flow information:    
Cash paid for interest 165 213
Amounts due for property and equipment included in accounts payable and accrued expenses 0 0
Amounts due for deferred offering costs included in accounts payable and accrued expenses 0 70
Fair value of warrants issued to underwriters in connection with Public Offering 0 3,485
Conversion of Facility Notes into Series B-2 Preferred Stock [Member]    
Supplemental cash flow information:    
Facility Notes principal converted to Series B-2 Preferred Stock 0 31,477
Warrants Issued in Connection with January 2021 Inducement Transaction [Member]    
Cash flows from financing activities:    
Proceeds from Inducement Transaction, net of discounts and commissions $ 0 $ 41,384